Greenwich LifeSciences raises ~$2.5M in private placement with CEO at $14.30/share

Greenwich LifeSciences, Inc.

CEO Snehal Patel purchased 174,825 shares at $14.30 (June 12 closing price) for ~$2.5M gross proceeds.
Shares are restricted securities, no registration rights; closing expected June 18, 2024.
Net proceeds to be used for clinical development and working capital.
Private placement is exempt under Section 4(a)(2) and Rule 506 of Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.